Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

HK$454.80As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6990Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 3Y CAGR 73.01%
Div yield —
ROE 2.92%
Biotechnology
Beta (5Y) 0.10
PE TTM 607.7
TSR TTM 1.52%
Mkt cap HK$108.7B
ROIC (0.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$463
1.76%
5.24%
Hold 4|8|12|0|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
6.20
6.56
6.71
6.91
4.25%
1.57%
8.45%
14.46%
Revenue¥B
9.079
9.213
9.686
9.398
(1.14%)
2.14%
10.28%
1.69%
Peers (US$13.87B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.363
0.045
0.048
EBIT/Intx
0.328
0.554
0.408
Own earn%
7.97
40.03
45.85
Sh yield%
28.70
42.59
40.17
Owners
Insiders/Inst%
5.67
38.38
Short interest%
4.27
SBC / revenue%
6.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
22–34
$1 testx
—
Incr. ROIC%
28